315 related articles for article (PubMed ID: 22591674)
1. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
Clem B; Telang S; Clem A; Yalcin A; Meier J; Simmons A; Rasku MA; Arumugam S; Dean WL; Eaton J; Lane A; Trent JO; Chesney J
Mol Cancer Ther; 2008 Jan; 7(1):110-20. PubMed ID: 18202014
[TBL] [Abstract][Full Text] [Related]
3. Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.
Chesney J; Clark J; Klarer AC; Imbert-Fernandez Y; Lane AN; Telang S
Oncotarget; 2014 Aug; 5(16):6670-86. PubMed ID: 25115398
[TBL] [Abstract][Full Text] [Related]
4. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
[TBL] [Abstract][Full Text] [Related]
5. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27.
Yalcin A; Clem BF; Imbert-Fernandez Y; Ozcan SC; Peker S; O'Neal J; Klarer AC; Clem AL; Telang S; Chesney J
Cell Death Dis; 2014 Jul; 5(7):e1337. PubMed ID: 25032860
[TBL] [Abstract][Full Text] [Related]
6. Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes.
Houddane A; Bultot L; Novellasdemunt L; Johanns M; Gueuning MA; Vertommen D; Coulie PG; Bartrons R; Hue L; Rider MH
Cell Signal; 2017 Jun; 34():23-37. PubMed ID: 28235572
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism.
Klarer AC; O'Neal J; Imbert-Fernandez Y; Clem A; Ellis SR; Clark J; Clem B; Chesney J; Telang S
Cancer Metab; 2014 Jan; 2(1):2. PubMed ID: 24451478
[TBL] [Abstract][Full Text] [Related]
9. Ras transformation requires metabolic control by 6-phosphofructo-2-kinase.
Telang S; Yalcin A; Clem AL; Bucala R; Lane AN; Eaton JW; Chesney J
Oncogene; 2006 Nov; 25(55):7225-34. PubMed ID: 16715124
[TBL] [Abstract][Full Text] [Related]
10. PFKFB3 promotes endotoxemia-induced myocardial dysfunction through inflammatory signaling and apoptotic induction.
Tian W; Guo HS; Li CY; Cao W; Wang XY; Mo D; Hao XW; Feng YD; Sun Y; Lei F; Zhang HN; Zhao MG; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 368():26-36. PubMed ID: 30776389
[TBL] [Abstract][Full Text] [Related]
11. Expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase/PFKFB3 isoforms in adipocytes and their potential role in glycolytic regulation.
Atsumi T; Nishio T; Niwa H; Takeuchi J; Bando H; Shimizu C; Yoshioka N; Bucala R; Koike T
Diabetes; 2005 Dec; 54(12):3349-57. PubMed ID: 16306349
[TBL] [Abstract][Full Text] [Related]
12. Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer.
Clem BF; O'Neal J; Tapolsky G; Clem AL; Imbert-Fernandez Y; Kerr DA; Klarer AC; Redman R; Miller DM; Trent JO; Telang S; Chesney J
Mol Cancer Ther; 2013 Aug; 12(8):1461-70. PubMed ID: 23674815
[TBL] [Abstract][Full Text] [Related]
13. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.
Yalcin A; Telang S; Clem B; Chesney J
Exp Mol Pathol; 2009 Jun; 86(3):174-9. PubMed ID: 19454274
[TBL] [Abstract][Full Text] [Related]
14. PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells.
Ozcan SC; Sarioglu A; Altunok TH; Akkoc A; Guzel S; Guler S; Imbert-Fernandez Y; Muchut RJ; Iglesias AA; Gurpinar Y; Clem AL; Chesney JA; Yalcin A
Mol Cell Biochem; 2020 Jul; 470(1-2):115-129. PubMed ID: 32415418
[TBL] [Abstract][Full Text] [Related]
15. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
[TBL] [Abstract][Full Text] [Related]
17. Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
Imbert-Fernandez Y; Clem BF; O'Neal J; Kerr DA; Spaulding R; Lanceta L; Clem AL; Telang S; Chesney J
J Biol Chem; 2014 Mar; 289(13):9440-8. PubMed ID: 24515104
[TBL] [Abstract][Full Text] [Related]
18. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis.
Chesney J
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):535-9. PubMed ID: 16912547
[TBL] [Abstract][Full Text] [Related]
19. 3PO inhibits inflammatory NFκB and stress-activated kinase signaling in primary human endothelial cells independently of its target PFKFB3.
Wik JA; Lundbäck P; la Cour Poulsen L; Haraldsen G; Skålhegg BS; Hol J
PLoS One; 2020; 15(3):e0229395. PubMed ID: 32130250
[TBL] [Abstract][Full Text] [Related]
20. Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.
Lypova N; Telang S; Chesney J; Imbert-Fernandez Y
J Biol Chem; 2019 Jul; 294(27):10530-10543. PubMed ID: 31126985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
